{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:31:41Z","timestamp":1773905501705,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,9]]},"DOI":"10.7759\/cureus.44941","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:36:16Z","timestamp":1694255776000},"source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Dr. SKS Hair Booster Serum in the Treatment of Female Pattern Alopecia in Patients With PCOS: An Open-Label, Non-randomized, Prospective Study"],"prefix":"10.7759","author":[{"given":"Stuti","family":"Khare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks S","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995, 333:853-61. 10.1056\/NEJM199509283331307","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100524","article-title":"Polycystic ovary syndrome: what more can be done for patients?","volume":"21","author":"The Lancet Regional Health-Europe","year":"2022","unstructured":"The Lancet Regional Health-Europe. Polycystic ovary syndrome: what more can be done for patients?. Lancet Reg Health Eur. 2022, 21:100524. 10.1016\/j.lanepe.2022.100524","journal-title":"Lancet Reg Health Eur"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02548","article-title":"Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee","volume":"104","author":"Carmina E","year":"2019","unstructured":"Carmina E, Azziz R, Bergfeld W, et al.. Female pattern hair loss and androgen excess: a report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019, 104:2875-91. 10.1210\/jc.2018-02548","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_249_17","article-title":"Update on management of polycystic ovarian syndrome for dermatologists","volume":"10","author":"Gainder S","year":"2019","unstructured":"Gainder S, Sharma B. Update on management of polycystic ovarian syndrome for dermatologists. Indian Dermatol Online J. 2019, 10:97-105. 10.4103\/idoj.IDOJ_249_17","journal-title":"Indian Dermatol Online J"},{"key":"ref5","article-title":"Female pattern hair loss: current treatment concepts","volume":"2","author":"Dinh QQ","year":"2007","unstructured":"Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007, 2:189-99.","journal-title":"Clin Interv Aging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2018.1439965","article-title":"Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study","volume":"20","author":"Kapoor R","year":"2018","unstructured":"Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018, 20:369-79. 10.1080\/14764172.2018.1439965","journal-title":"J Cosmet Laser Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky AW","year":"2004","unstructured":"Lucky AW, Piacquadio DJ, Ditre CM, et al.. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004, 50:541-53. 10.1016\/j.jaad.2003.06.014","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen EA","year":"2002","unstructured":"Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002, 47:377-85. 10.1067\/mjd.2002.124088","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma IH","year":"2014","unstructured":"Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2014, 80:521-5. 10.4103\/0378-6323.144162","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12588","article-title":"Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg\/day in women with female pattern hair loss","volume":"31","author":"Won YY","year":"2018","unstructured":"Won YY, Lew BL, Sim WY. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg\/day in women with female pattern hair loss. Dermatol Ther. 2018, 31:e12588. 10.1111\/dth.12588","journal-title":"Dermatol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.114709","article-title":"Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women","volume":"5","author":"Oliveira-Soares R","year":"2013","unstructured":"Oliveira-Soares R, E Silva JM, Correia MP, Andr\u00e9 MC. Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women. Int J Trichology. 2013, 5:22-5. 10.4103\/0974-7753.114709","journal-title":"Int J Trichology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price VH","year":"2000","unstructured":"Price VH, Roberts JL, Hordinsky M, et al.. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000, 43:768-76. 10.1067\/mjd.2000.107953","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)04551-x","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina E","year":"2003","unstructured":"Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003, 79:91-5. 10.1016\/s0015-0282(02)04551-x","journal-title":"Fertil Steril"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P600","article-title":"Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss","volume":"45","author":"Paradisi R","year":"2011","unstructured":"Paradisi R, Porcu E, Fabbri R, Seracchioli R, Battaglia C, Venturoli S. Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss. Ann Pharmacother. 2011, 45:469-75. 10.1345\/aph.1P600","journal-title":"Ann Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau P","year":"2002","unstructured":"Vexiau P, Chaspoux C, Boudou P, Fiet J, Jouanique C, Hardy N, Reygagne P. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol. 2002, 146:992-9. 10.1046\/j.1365-2133.2002.04798.x","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S398950","article-title":"The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review","volume":"16","author":"Wang C","year":"2023","unstructured":"Wang C, Du Y, Bi L, Lin X, Zhao M, Fan W. The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review. Clin Cosmet Investig Dermatol. 2023, 16:603-12. 10.2147\/CCID.S398950","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37424","article-title":"The efficacy and safety of Dr. SKS Hair Booster Serum (a cocktail of micronutrients and multivitamins) in adult males and females with androgenetic alopecia: an open-label, non-randomized, prospective study","volume":"15","author":"Khare S","year":"2023","unstructured":"Khare S. The efficacy and safety of Dr. SKS Hair Booster Serum (a cocktail of micronutrients and multivitamins) in adult males and females with androgenetic alopecia: an open-label, non-randomized, prospective study. Cureus. 2023, 15:e37424. 10.7759\/cureus.37424","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3329\/jbsp.v14i1.41997","article-title":"Serum zinc and copper levels in alopecia","volume":"14","author":"Rahman F","year":"2019","unstructured":"Rahman F, Akhter QS. Serum zinc and copper levels in alopecia. J Bangladesh Soc Physiol. 2019, 14:21-5. 10.3329\/jbsp.v14i1.41997","journal-title":"J Bangladesh Soc Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5021\/ad.1997.9.4.239","article-title":"Analysis of serum zinc and copper levels in alopecia areata","volume":"9","author":"Lee SY","year":"1997","unstructured":"Lee SY, Nam KS, Seo YW, Lee JS, Chung H. Analysis of serum zinc and copper levels in alopecia areata. Ann Dermatol. 1997, 9:239-41. 10.5021\/ad.1997.9.4.239","journal-title":"Ann Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2005.31732","article-title":"Niacinamide: A B vitamin that improves aging facial skin appearance","volume":"31","author":"Bissett DL","year":"2005","unstructured":"Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005, 31:860-5; discussion 865. 10.1111\/j.1524-4725.2005.31732","journal-title":"Dermatol Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12235","article-title":"Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia","volume":"37","author":"Watanabe Y","year":"2015","unstructured":"Watanabe Y, Nagashima T, Hanzawa N, et al.. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia. Int J Cosmet Sci. 2015, 37:579-87. 10.1111\/ics.12235","journal-title":"Int J Cosmet Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1515\/pac-2017-0314","article-title":"Preparation and characterization of collagen\/chitosan\/hyaluronic acid thin films for application in hair care cosmetics","volume":"89","author":"Sionkowska A","year":"2017","unstructured":"Sionkowska A, Kaczmarek B, Michalska M, Lewandowska K, Grabska S. Preparation and characterization of collagen\/chitosan\/hyaluronic acid thin films for application in hair care cosmetics. Pure Appl Chem. 2017, 89:1829-39. 10.1515\/pac-2017-0314","journal-title":"Pure Appl Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2014.07.058","article-title":"Synthesis and characterization of hyaluronic acid\/human-like collagen hydrogels","volume":"43","author":"Zhang J","year":"2014","unstructured":"Zhang J, Ma X, Fan D, Zhu C, Deng J, Hui J, Ma P. Synthesis and characterization of hyaluronic acid\/human-like collagen hydrogels. Mater Sci Eng C Mater Biol Appl. 2014, 43:547-54. 10.1016\/j.msec.2014.07.058","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/530121","article-title":"The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases","volume":"2012","author":"Azzouni F","year":"2012","unstructured":"Azzouni F, Godoy A, Li Y, Mohler J. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012, 2012:530121. 10.1155\/2012\/530121","journal-title":"Adv Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00385.x","article-title":"Familial uncombable hair syndrome: ultrastructural hair study and response to biotin","volume":"24","author":"Boccaletti V","year":"2007","unstructured":"Boccaletti V, Zendri E, Giordano G, Gnetti L, De Panfilis G. Familial uncombable hair syndrome: ultrastructural hair study and response to biotin. Pediatr Dermatol. 2007, 24:E14-6. 10.1111\/j.1525-1470.2007.00385.x","journal-title":"Pediatr Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(85)70150-8","article-title":"Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia","volume":"13","author":"Shelley WB","year":"1985","unstructured":"Shelley WB, Shelley ED. Uncombable hair syndrome: observations on response to biotin and occurrence in siblings with ectodermal dysplasia. J Am Acad Dermatol. 1985, 13:97-102. 10.1016\/s0190-9622(85)70150-8","journal-title":"J Am Acad Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.188040","article-title":"Serum biotin levels in women complaining of hair loss","volume":"8","author":"Tr\u00fceb RM","year":"2016","unstructured":"Tr\u00fceb RM. Serum biotin levels in women complaining of hair loss. Int J Trichology. 2016, 8:73-7. 10.4103\/0974-7753.188040","journal-title":"Int J Trichology"},{"key":"ref28","article-title":"Riboflavin deficiency","author":"Mahabadi N","year":"2022","unstructured":"Mahabadi N, Bhusal A, Banks SW. Riboflavin deficiency. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2013.28.6.934","article-title":"Iron plays a certain role in patterned hair loss","volume":"28","author":"Park SY","year":"2013","unstructured":"Park SY, Na SY, Kim JH, Cho S, Lee JH. Iron plays a certain role in patterned hair loss. J Korean Med Sci. 2013, 28:934-8. 10.3346\/jkms.2013.28.6.934","journal-title":"J Korean Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174013-efficacy-of-dr-sks-hair-booster-serum-in-the-treatment-of-female-pattern-alopecia-in-patients-with-pcos-an-open-label-non-randomized-prospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:18Z","timestamp":1707509118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174013-efficacy-of-dr-sks-hair-booster-serum-in-the-treatment-of-female-pattern-alopecia-in-patients-with-pcos-an-open-label-non-randomized-prospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.44941","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,9]]}}}